Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® ( Solriamfetol ) Patent Litigation with Sandoz Inc. - Axsome Therapeutics ( NASDAQ:AXSM )

4 weeks ago

NEW YORK, Aug. 21, 2024 ( GLOBE NEWSWIRE ) -- Axsome Therapeutics, Inc. AXSM, a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced that it has reached agreement with Sandoz Inc. ( Sandoz ) to dismiss the ...

Ticker	Sentiment	Impact
AXSM	Neutral	23 %